Literature DB >> 21191857

Test non-inferiority and sample size determination based on the odds ratio under a cluster randomized trial with noncompliance.

Kung-Jong Lui1, Kuang-Chao Chang.   

Abstract

Because the odds ratio (OR) possesses certain desirable statistical properties, the OR has been recommended elsewhere to measure the relative treatment effect in establishing non-inferiority. For cost efficiency, we may often employ a cluster randomized trial (CRT), in which randomized units are clusters of patients. Furthermore, it is not uncommon to encounter data in which there are patients not complying with their assigned treatment. Under the Dirichlet multinomial model, we have developed a test statistic for assessing non-inferiority based on the OR between two treatments under a CRT with noncompliance. We have further derived a sample size formula accounting for both noncompliance and the intraclass correlation for a desired power 1 - β of detecting non-inferiority with respect to the OR at a nominal α level. Using Monte Carlo simulation, we have evaluated the performance of the proposed test statistic and sample size formula. Finally, we use the CRT studying the effect of vitamin A supplementation on mortality among preschool children to illustrate the use of the sample size formula given here.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21191857     DOI: 10.1080/10543401003602623

Source DB:  PubMed          Journal:  J Biopharm Stat        ISSN: 1054-3406            Impact factor:   1.051


  5 in total

1.  Bayesian Design of Non-Inferiority Clinical Trials via the Bayes Factor.

Authors:  Wenqing Li; Ming-Hui Chen; Xiaojing Wangy; Dipak K Dey
Journal:  Stat Biosci       Date:  2017-07-06

2.  Methods for sample size determination in cluster randomized trials.

Authors:  Clare Rutterford; Andrew Copas; Sandra Eldridge
Journal:  Int J Epidemiol       Date:  2015-07-13       Impact factor: 7.196

3.  What are the statistical implications of treatment non-compliance in cluster randomized trials: A simulation study.

Authors:  Mirjam Moerbeek; Sander van Schie
Journal:  Stat Med       Date:  2019-10-03       Impact factor: 2.373

Review 4.  A review of prospective Clinical Trials for neurogenic bladder: Pharmaceuticals.

Authors:  Cristian Persu; Emmanuel Braschi; John Lavelle
Journal:  Cent European J Urol       Date:  2014-08-18

Review 5.  A review of prospective Clinical Trials for neurogenic bladder: The place of surgery, experimental techniques and devices.

Authors:  Cristian Persu; Emmanuel Braschi; John Lavelle
Journal:  Cent European J Urol       Date:  2014-08-18
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.